Overall rank by patents
#24,940
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI).
The verdict
According to USPTO PatentsView, Olympic ranks #24,940 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R24940 · US Corporation #24,940 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Ohemo Life Sciences, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Olympic Ophthalmics · this assignee
34 score
3D Lighting Innovati… · lowest
7 score
What this shows Olympic's Innovation Score is 33.5/100 (top 55% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Olympic Ophthalmics, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI). Peak complete grant year is 2021 (6 grants) versus a trough of 1 in 2020. By volume, Olympic sits between Ohemo Life Sciences, Inc. and Optimotion Implants Llc.
Olympic Ophthalmics, Inc. shows 3 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Ohemo Life Sciences, Inc.
11 patents
Oki Data Infotech Corporation
11 patents
Old Dominion Brush Company
11 patents
Oliden Technology, LLC
11 patents
Onset Medical, Inc.
11 patents
Open Access Technology International, Inc.
11 patents
Open Drives, Inc.
11 patents
Optimotion Implants LLC
11 patents
Olympic Ophthalmics, Inc.
11 patents
What this shows Olympic holds 11 patents at rank #24,940, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #24,940 in granted patent volume.
Other assignees with the most granted patents in Olympic's primary technology class.
Olympic's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 Top 55% higher than 45% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 9.1% |
| 2021 | 6 | 54.5% |
| 2022 | 1 | 9.1% |
| 2023 | 1 | 9.1% |
| 2024 | 1 | 9.1% |
| 2025partial year | 1 | 9.1% |
Top 4 of 4 technology areas
Overall rank by patents
#24,940
of 50,000 tracked assignees
33.5 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.